| Class 2 Device Recall IGFBP3 ELISA Reagent Kit | |
Date Initiated by Firm | March 30, 2011 |
Date Posted | May 11, 2011 |
Recall Status1 |
Terminated 3 on December 02, 2011 |
Recall Number | Z-2184-2011 |
Recall Event ID |
58583 |
510(K)Number | K951707 |
Product Classification |
Radioimmunoassay, human growth hormone - Product Code CFL
|
Product | IGFBP-3 ELISA Reagent Kit; Part Number" DSL-10-6600; Lot Numbers: 992743, 992287, 991916, 991530, 991432, 990220 & 890830
This assay is intended for in vitro diagnostic use. |
Code Information |
Lot Numbers: 992743, 992287, 991916, 991530, 991432, 990220 & 890830 |
Recalling Firm/ Manufacturer |
Beckman Coulter Inc. 250 S Kraemer Blvd Brea CA 92821-6232
|
Manufacturer Reason for Recall | The recall was was initiated because patient results with the IGFBP-3 ELISA kit may be elevated by 70% compared to stated expected ranges in the Instructions for Use (IFU). |
FDA Determined Cause 2 | Process control |
Action | Beckman Coulter sent a Product Corrective Action (PCA) letter with attached customer response form on March 30, 2011 to all customers who have the affected product, IGFBP- 3 Enzyme-Linked immunosorbent Assay ( ELISA) kit .This kit provides materials for the quantitative measurement of IGFBP-3 in serum. The letter informed the customers of the reason for recall, the products affected and actions to be taken.
Consignees were asked to share this information with their laboratory staff and retain the notification as part of their laboratory Quality System documentation. If they forwarded any of the affected product listed above to another laboratory, they were asked to provide a copy of the letter to them.
Beckman further asked consignees to complete and return the enclosed Response Form within 10 days so they are assured consignees have received this important communication.
Questions were directed to the Beckman Coulter Customer Support Center.
- Website: http://www.beckmancoulter.com/customersupport/support
- Phone, call 1-800-854-3633 in the United States and Canada
- Outside the United States and Canada contact local Beckman Coulter representative. |
Quantity in Commerce | 1,212 units |
Distribution | Worldwide -- USA, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Greece, Hong Kong, India, Italy, Korea, Republic of, Lebanon, Luxembourg, Morocco, Netherlands, New Zealand, Puerto Rico, Syrian Arab Republic, Taiwan, Thailand, Turkey & United Kingdom |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = CFL
|
|
|
|